Biogen drops controversial Alzheimer's drug, focuses on other treatments - Fox Business
foxbusiness.comSubmitted by foxbusiness4472 in business
Biogen will discontinue development of its controversial drug Aduhelm so it can shift efforts to other drugs, including Leqembi, which it developed with Eisai.